Molecular genetics of Alzheimer's disease

Author: Hardy, J.

Source: Acta Neurologica Scandinavica, Volume 94, Supplement 165, 1 April 1996 , pp. 13-17(5)

Publisher: Wiley-Blackwell

Buy & download fulltext article:

OR

Price: $48.00 plus tax (Refund Policy)

Abstract:

Four genes have thus far been implicated in the etiology of Alzheimer's disease (AD). A series of mutations in the amyloid precursor protein (APP) gene on chromosome 21, which cause disease with a typical onset of 55 years of age, have been described. These include mutations at APP670/671, APP692, and APP717. The ε4 allele of the apolipoprotein E (ApoE) gene on chromosome 19 is positively associated with disease, whereas the ε2 allele is usually negatively associated with disease. Mutations in the S182 gene on chromosome 14 seem to cause disease with an onset age of <50 years and mutations in a gene on chromosome 1 (S182 Like Protein: S182LP) cause disease with variable onset. These genetic findings are reviewed within the framework of the amyloid cascade hypothesis of AD etiology and pathogenesis. The occurrence and effects of the mutations in APP and the fact that the ε4 allele of ApoE are genetic risk factors point to the hypothesis that the extracellular deposition of β‐amyloid is the key initiating event in the pathogenesis of AD.

Document Type: Original Article

DOI: http://dx.doi.org/10.1111/j.1600-0404.1996.tb05867.x

Affiliations: Alzheimer's Research Laboratory, University of South Florida, Tampa, USA

Publication date: April 1, 1996

Related content

Tools

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page